Topiramate
NDC 10370-365 · Endo USA, Inc.
Generic nameTopiramate
Dosage formCAPSULE, EXTENDED RELEASE
RouteORAL
Active ingredient(s)TOPIRAMATE
Strength25 mg/1
Pharmacologic classCytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]
Marketing categoryANDA
Packages
10370-365-01 — 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10370-365-01)
10370-365-11 — 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10370-365-11)
Related Codes
Same active ingredient
FDA lists these products with the same active ingredient.
0615-8593 — Topiramate, 0615-8594 — Topiramate, 0615-8595 — Topiramate, 0832-1071 — Topiramate, 0832-1072 — Topiramate, 0832-1073 — Topiramate, 0832-1074 — Topiramate, 0832-1075 — Topiramate, 0904-6928 — topiramate, 0904-6929 — topiramate, 10370-366 — Topiramate, 10370-367 — Topiramate, 10370-368 — Topiramate, 17772-101 — topiramate, 17772-102 — topiramate, 17772-103 — topiramate, 17772-104 — topiramate, 23155-894 — topiramate spinkle, 24979-210 — Topiramate, 24979-211 — Topiramate, +289 more